Nasdaq Turns Higher; Akumin Shares Jump

Published 23/10/2023, 17:06
© Reuters.  Nasdaq Turns Higher; Akumin Shares Jump
IXIC
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stocks pared losses midway through trading, with the Nasdaq Composite gaining over 60 points on Monday.

The Dow traded down 0.01% to 33,126.50 while the NASDAQ rose 0.54% to 13,054.00. The S&P 500 also rose, gaining, 0.29% to 4,236.55.

Check This Out: This Analyst With 85% Accuracy Rate Sees More Than 42% Upside In Amazon.com - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

Leading and Lagging Sectors

Communication services shares rose by 0.9% on Monday.

In trading on Monday, energy shares dipped by 1%.

Top Headline

The Chicago Fed National Activity Index climbed to +0.02 in September versus a revised reading of -0.22 in the prior month.

Equities Trading UP

LumiraDx Limited (NASDAQ: LMDX) shares shot up 205% to $0.2650 after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub.

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) got a boost, shooting 337% to $2.36 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.

Akumin Inc. (NASDAQ: AKU) shares were also up, gaining 154% to $0.3703 after the company reached an agreement with Stonepeak to become a private company.

Equities Trading DOWN

Li-Cycle Holdings Corp. (NYSE: LICY) shares dropped 42% to $1.3082 after the company announced plans to halt construction work on its Rochester Hub project, pending completion of a comprehensive review of the go-forward strategy for the project..

Shares of Revolution Medicines, Inc. (NASDAQ: RVMD) were down 43% to $16.00 after the company announced it presented clinical activity and safety data from its Phase 1/1b trial of RMC-6236.

Apollomics, Inc. (NASDAQ: APLM) was down, falling 40% to $1.04 after the company announced the presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial at ESMO 2023.

Also Check This Out: Top 4 Consumer Stocks That May Crash This Quarter

Commodities

In commodity news, oil traded down 2% to $86.39 while gold traded down 0.3% at $1,988.50.

Silver traded down 1.2% to $23.225 on Monday while copper rose 0.4% to $3.5765.

Euro zone

European shares were mixed today. The eurozone’s STOXX 600 fell 0.12%, London’s FTSE 100 fell 0.36% while Spain’s IBEX 35 Index fell 0.41% The German DAX fell 0.03% French CAC 40 rose 0.51%, while Italy’s FTSE MIB Index gained 0.80%.

Asia Pacific Markets

Asian markets closed lower on Monday, with Japan’s Nikkei 225 falling 0.83% and China’s Shanghai Composite Index falling 1.47%. India’s S&P BSE Sensex, meanwhile, fell 0.8%.

Food prices in Singapore rose by 4.3% year-over-year in September following a 4.8% increase in August. Singapore's annual inflation rate rose to 4.1% in September from August's level of 4.0%.

Economics

The Chicago Fed National Activity Index climbed to +0.02 in September versus a revised reading of -0.22 in the prior month.

Now Read This: $15M Bet On Day One Biopharmaceuticals? Check Out These 3 Stocks Insiders Are Buying

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.